AIxMed
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $7.8M
Investors
- 2
About AIxMed
Established in 2018 by Samuel Chen and TJ Liu, and founded in California, US, AIxMed, Inc. uses an AI-powered (artificial intelligence) computational platform that enables pathologists to scan 3D cytology samples and extract clinical insights in lesser time. The company employs artificial intelligence and computer vision to provide pathologists with an intuitive and computational user interface platform that allows them to discover deep insights in cytology samples. The company's platform focuses on urine cytology, cervical cytology, and thyroid cytology to deliver clinical insights acquired from full samples in order to provide fast diagnosis, update results on the cloud, and eliminate manual labor.
Who invested in AIxMed
2 investors across 1 round
See all investors in AIxMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 31, 2021
Amount
$7.8M
Investors
Questions about AIxMed
Who invested in AIxMed?
AIxMed has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AIxMed raised?
AIxMed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AIxMed last raise money?
AIxMed's most recent round on record is a Series A, in Aug 2021.
What does AIxMed do?
Established in 2018 by Samuel Chen and TJ Liu, and founded in California, US, AIxMed, Inc.
Where is AIxMed headquartered?
AIxMed is headquartered in Santa Clara, US.
Which VCs invest in companies like AIxMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at AIxMed's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like AIxMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.